{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/294065682"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Professor Mark Peakman from King???s College London said: ???MultiPepT1De has some important advantages over current approaches to the prevention of Type 1 diabetes, especially its ability to avoid global immune suppression which is a problem with several other approaches under consideration. ???Peptide immunotherapy is being explored in other diseases, such as allergies and multiple sclerosis, us" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "medicalxpress.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/438868757"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/294065682" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/26769955"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/294065682"] } } }
